Español
Questions About Cancer? 1-800-4-CANCER

All News Releases

UT Southwestern researchers note that signaling mechanism could be target for survival, growth of tumor cells in brain cancer
NCI Cancer Center News
(Posted: 12/15/2014) - UT Southwestern Medical Center neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target.

U Penn Medical School researchers find that most women with early-stage breast cancer in US receive radiation for too long
NCI Cancer Center News
(Posted: 12/11/2014) - Two-thirds of women treated for early-stage breast cancer in the US receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicine.

Premenopausal women who received ovarian suppression treatment along with tamoxifen had a lower risk of breast cancer recurrence
NCI News Note
(Posted: 12/11/2014) - A clinical trial sponsored and supported by NCI showed that suppressing ovarian function reduced breast cancer recurrence in premenopausal women receiving the drug tamoxifen after surgery for early-stage breast cancer.

Ohio State U study finds that experience counts with radiation therapy for head and neck cancer
NCI Cancer Center News
(Posted: 12/09/2014) - Radiation therapy for head and neck cancer is highly complex, and a new study published in the Journal of Clinical Oncology with an accompanying editorial suggests that medical centers with more experience centers have better patient outcomes.

Dana-Farber researchers find that a new agent causes small cell lung tumors to shrink in pre-clinical testing
NCI Cancer Center News
(Posted: 12/09/2014) - Small cell lung cancer has shown itself vulnerable to an agent that disables part of tumor cells’ basic survival machinery, researchers at Dana-Farber Cancer Institute and the Massachusetts Institute of Technology reported.

Dana-Farber researchers find that a new agent causes small cell lung tumors to shrink in pre-clinical testing
NCI Cancer Center News
(Posted: 12/09/2014) - Small cell lung cancer has shown itself vulnerable to an agent that disables part of tumor cells’ basic survival machinery, researchers at Dana-Farber Cancer Institute and the Massachusetts Institute of Technology reported.

Dana-Farber researchers find that a narrow subset of cells is responsible for metastasis in multiple myeloma
NCI Cancer Center News
(Posted: 12/08/2014) - Dana-Farber researchers report that multiple myeloma is driven to spread by a subset of the myeloma cells within a patient’s body, and that attacking those specific subsets with targeted drugs may be better targets for therapy.

Dana-Farber researchers report immunotherapy results in patients with Hodgkin lymphoma
NCI Cancer Center News
(Posted: 12/08/2014) - Eighty-seven percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.

Mayo researchers see benefit in test of three-drug treatment for multiple myeloma
NCI Cancer Center News
(Posted: 12/08/2014) - In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic.

Duke researchers find that older breast cancer patients still get radiation despite limited benefit
NCI Cancer Center News
(Posted: 12/08/2014) - Women over the age of 70 who have certain early-stage breast cancers overwhelmingly receive radiation therapy despite published evidence that the treatment has limited benefit, researchers at Duke Medicine report.

< Previous  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >